Patent information is used far beyond the process of filing a patent application itself. Companies rely on published patent documents to negotiate licensing deals, guide their own research and development, and understand what technology is already available to use freely. Governments and policymakers also draw on patent data to shape innovation policy, as the case studies below illustrate.
1.7 How patent information can be Used: Real-World Case Studies
The five cases below show how organizations and governments have put patent information to practical use, whether to close a licensing deal, catch up technologically, or shape national policy. Each one highlights a different way that reading and analyzing patent documents can turn into real commercial or economic value.
1.7.1 Case study 1: Licensing agreement
Pliva, once Croatia's largest pharmaceutical manufacturer, patented the antibiotic azithromycin in 1980. A year later, researchers at Pfizer came across Pliva's patent while combing through records at the US Patent and Trademark Office. That discovery led to a licensing deal: Pfizer would market the drug worldwide under the brand name Zithromax, while Pliva collected royalties.
The arrangement transformed Pliva's finances. By 1999, according to an estimate from Daiwa Institute of Research Europe analyst Nigel Keegan, royalty income and bulk-sale margins from azithromycin made up more than three-quarters of the company's operating profit, and Zithromax sales themselves had already passed the $1 billion mark. The revenue funded Pliva's expansion into Poland and Russia. None of it would have happened if a routine patent search hadn't surfaced the original filing.
Cases like this show how much value a single overlooked patent can hold. WOIPS' AI-powered Novelty Search can help you quickly surface relevant existing patents in your own field, before a competitor does.
1.7.2 Case study 2: Patent information research
India's rise as a major exporter of generic medicines during the 1990s is often told as a story of low-cost manufacturing, but patent information played a quieter, less-discussed role. Indian pharmaceutical companies built up their technical expertise largely by studying patents that had been filed and published in other countries but never registered in India, since the original patent holders had no commercial interest there.
Because those inventions were unprotected within Indian borders, the technical details in the patent documents were free for local firms to study and use. This let Indian manufacturers close a substantial technology gap with limited outside assistance, an approach other developing economies could replicate wherever they build stronger awareness of publicly available patent information.
Source: Carsten Fink and Keith Maskus, Intellectual Property and Development, Oxford University Press and the World Bank (2004), p. 230.
Whether you're evaluating a licensing opportunity, solving a technical challenge, or simply want to know what's already been patented in your space, you can submit your invention for a free AI-powered prior art assessment and get clear, actionable results in minutes.
1.7.3 Case study 3: Patent information and marketing/investment strategy
Takashi Ishikawa, a former carpenter specializing in temple construction, noticed that cases of stroke were unusually common in his region during harsh winters. Suspecting a link to poorly insulated housing, he set out to design a better exterior wall material, insulated metal siding, and left carpentry to start his own company.
The missing piece was insulation. Ishikawa found his answer, almost by accident, while resting under a traditional futon on a cold morning and noticing how well it retained heat; the filling turned out to be urethane foam, a material he knew little about at the time. A trip to the Japan Patent Office to review published, unexamined applications gave him the technical grounding he needed: urethane foam is made by combining polyol and polyisocyanate with a foaming agent. The core patent covering the process, held by an overseas manufacturer, was set to expire in June 1971, with related patents following in 1973, after which the underlying technology would be free to use without licensing fees.
Several major steel manufacturers turned down Ishikawa's idea of pairing metal panels with urethane foam, viewing it as too unconventional for the construction industry. He built the product himself instead. Early attempts failed repeatedly, and he came close to giving up more than once, but by 1976 he had worked out a process that sped up the foam's solidification and cut production costs, and the product succeeded commercially soon after. Ishikawa later remarked that patent research, once limited to in-person visits to the patent office, is now available online, giving companies outside major industrial hubs the same access to technology trends as anyone else. His company, IG Kogyo, now holds more than 10,000 industrial property rights (including pending applications), a striking output for a firm capitalized at roughly 150 million yen (about $1.25 million).
1.7.4 Case study 4: Using patent information to solve a technical problem
Rica Industries, a Malaysian chemical manufacturer with under 150 employees and annual revenue below $8 million, started out licensing formulations and know-how from foreign technology providers, paying a steady stream of royalties for the privilege. To cut those costs, the company built its own R&D unit to develop proprietary formulations instead.
Patent documents became one of the team's core research tools; its lead chemist later described patent literature as a genuine source of ideas, since different patents on the same problem tend to reveal different ways of solving it. That mindset paid off in the metal-cabinet industry. Standard practice there treats mild steel sheets with an iron phosphate solution inside a heat-treatment chamber running at 50–70°C, before painting, but building and running that chamber is expensive. Rica's researchers used technical journals and patent documents to develop a formulation that could treat the steel at room temperature instead, eliminating the chamber altogether, and patented the results (see US 3060066, US 4017335, US 4149909, and US 5137589).
Not every idea they tried worked, but the team consistently credited the patent literature with supplying useful leads and shortening their development timeline, since it let them build on existing approaches rather than reinvent them and compare their own results against what was already disclosed.
1.7.5 Case study 5: Patent information as an ingredient in policy making (US Bayh–Dole Act)
Patent information doesn't only shape company strategy; it can also inform national policy. By 1980, the US federal government held roughly 30,000 patents from federally funded research, yet fewer than 5% had ever turned into a marketed product, largely because no institutional mechanism existed to commercialize them.
Senators Birch Bayh and Bob Dole used that patent data to build the case for what became the Bayh–Dole Act, legislation that let universities, small businesses, and nonprofits retain ownership of federally funded inventions and license them, including exclusively, to private companies. The goal was to give those institutions enough incentive to pursue commercialization themselves.
The results were substantial: thousands of startups have since launched on university-licensed technology, and academic licensing is estimated to add tens of billions of dollars a year to the US economy, supporting innovations that include MRI advances at the University of Wisconsin–Madison, nanoscale lithography developed at the University of Texas at Austin, and aneurysm treatments from UCLA. Two decades later, commentators still cite it as one of the most consequential pieces of US legislation of its era, a reminder that patent data can serve policymakers just as well as it serves inventors and companies.
Frequently Asked Questions
What is patent information used for besides filing a patent? Beyond protecting an invention, published patent documents serve as a rich source of technical and business intelligence. Companies and researchers use them to identify licensing opportunities, track competitors' technology, avoid duplicating existing research, and even shape investment or policy decisions, as the case studies above illustrate.
Can I legally use technology described in an expired or unregistered patent?
Yes. Once a patent expires, or if it was never filed in a particular country, the technical information it discloses generally becomes free to use in that jurisdiction without needing a license.
This is exactly how many manufacturers, including generic drug producers, have historically built up technical capability by studying patents that had lapsed or were never extended to their market.
How can a small or mid-sized company benefit from patent information without a large R&D budget? Patent documents are public and freely searchable, so even companies with limited research budgets can use them to study how others have solved similar technical problems. As one of the case studies above shows, a lead chemist can find alternative formulations or processes already disclosed in existing patents, which shortens development time and reduces the cost of starting from scratch.
Can patent information really influence government policy? Yes. Patent statistics and licensing data can reveal broader economic patterns, such as how much publicly funded research goes unused. That kind of data-driven analysis was part of the reasoning behind the US Bayh-Dole Act, which changed how ownership of federally funded inventions was handled in order to encourage more of them to reach the market.
Where can I search for published patent information myself? Patent offices such as the USPTO, EPO, and JPO, along with WIPO's global PATENTSCOPE database, all offer free public search tools for published patent applications and granted patents. For a faster overview tailored to a specific invention, WOIPS' AI-powered Novelty Search can also scan across these sources automatically and highlight the most relevant results.
This article draws on publicly available WIPO materials and real-world patent case studies for illustrative purposes; content has been adapted and is not an official WIPO publication.